Lv11
40 积分 2023-07-22 加入
[Efficacy Analysis of Bendamustine-Based Combination Regimen in Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma]
15天前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
2个月前
已完结
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma
2个月前
已完结
Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial
2个月前
已完结
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma
2个月前
已完结
A.R.R.O.W.2: Once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma
4个月前
已关闭
A.R.R.O.W.2: Once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma
4个月前
已完结
Radiotherapy activates picolinium prodrugs in tumours
4个月前
已完结
Fever of Unknown Origin
5个月前
已完结
Management of fever and neutropenia in the adult patient with acute myeloid leukemia
5个月前
已完结
皖公网安备34019202002308
